Image

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Recruiting
8-25 years
All
Phase N/A

Powered by AI

Overview

This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))

Description

Physical activity in childhood is an integral part of maintaining health and quality of life. Children who participate in routine physical activity are more likely to maintain a healthy body weight and are less likely to have heart disease, type 2 diabetes and high blood pressure as adults. Children with chronic disease are often limited from full participation in exercise for various reasons -perceived physical limitations, either from the patient and family or from their medical provider, or because of symptoms which cause exercise to feel uncomfortable. As the number of children living and aging with chronic disease continues to grow, the researchers are hoping to expand the current exercise testing capabilities for both clinical care and research in order to (i) provide data to permit formulation of evidence-based guidelines for exercise in chronic childhood disease; (ii) improve understanding of limitations to exercise in this growing population; (iii) learn long-term implications of chronic childhood disease as these individuals enter adulthood.

Eligibility

Inclusion Criteria:

  • Cases:
    • Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
    • 8-25 years old
    • Height: ≥ 48 inches
    • Ambulatory without assistance
    • English speaking
    • Normotensive (<95th percentile for age; okay if managed with antihypertensive medication)
    • SpO2 >92%
    • Not pregnant
    • ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry
  • Controls
    • 8-25 years old
    • Height: ≥ 48 inches
    • Ambulatory without assistance
    • English speaking
    • No history of arrhythmia or known cardiac dysfunction at baseline
    • Normotensive (<95th percentile for age; okay if managed with antihypertensive medication)
    • SpO2 >95%
    • Not pregnant

Exclusion Criteria:

  • Cases:
    • ALL specific: received cranial radiation, bone marrow transplant recipients
    • Investigator or patient's primary physician deems the patient unsuitable for the study
  • Controls:
    • History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function
    • Investigator deems the patient unsuitable for the study

Study details
    Chronic Lung Disease
    Chronic Obstructive Pulmonary Disease
    Acute Lymphoblastic Leukemia
    Heart Transplant

NCT05025774

Masonic Cancer Center, University of Minnesota

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.